BONE BIOLOGICS CORP (BBLG) Stock Earnings & Estimates
NASDAQ:BBLG - US0980705018 - Common Stock
2.2 USD
+0.03 (+1.38%)
2.2 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | ||||||||||||
| EBITDA YoY % growth | -2.13M | -12M -463.38% | -20.41M -70.08% | -2.63M 87.11% | -2.79M -6.08% | -2.45M 12.19% | -830K 66.12% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.13M | -12M -463.38% | -20.41M -70.08% | -2.63M 87.11% | -2.79M -6.08% | -2.45M 12.19% | -830K 66.12% | -1.1M -32.53% | -3.67M -233.64% | -9.428M -156.90% | -4.219M 55.25% | N/A 8.04% | N/A -10.07% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -604.80 37.61% | -398.34 34.14% | -29.78 92.52% | N/A 86.23% | N/A 0.75% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -1.25 91.18% | -1.16 68.44% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -1.088M -14.44% | -1.111M 28.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.33 66.92% | -0.59 | -0.74 | -124.81% |
| Q1 2025 Q2Q % growth | -1.92 75.57% | -2.94 | 1.02 | 34.64% |
| Q4 2024 Q2Q % growth | -3.68 75.14% | -3.98 | 0.29 | 7.39% |
| Q3 2024 Q2Q % growth | -14.22 51.43% | -3.67 | -10.55 | -287.25% |
| Q2 2024 Q2Q % growth | -4.02 82.55% | -8.51 | 4.49 | 52.74% |
| Q1 2024 Q2Q % growth | -7.86 97.63% | -46.51 | 38.65 | 83.10% |
| Q4 2023 Q2Q % growth | -14.82 94.28% | -34.27 | 19.45 | 56.76% |
| Q3 2023 Q2Q % growth | -29.28 83.06% | -148.84 | 119.56 | 80.33% |
| Q2 2023 Q2Q % growth | -23.04 68.00% | -73.44 | 50.40 | 68.63% |
| Q1 2023 Q2Q % growth | -331.20 -228.57% | -102.82 | -228.38 | -222.13% |
| Q4 2022 Q2Q % growth | -259.20 -3.81% | -330.48 | 71.28 | 21.57% |
| Q3 2022 Q2Q % growth | -172.80 -101,547.06% | -220.32 | 47.52 | 21.57% |
| Q2 2022 Q2Q % growth | -72.00 | -176.26 | 104.26 | 59.15% |
| Q1 2022 Q2Q % growth | -100.80 | -293.76 | 192.96 | 65.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -81.25% | 0% | -58.2% |
| Revenue | N/A | N/A | N/A | N/A |